[Noncardiac surgery and congenital heart diseases: pathophysiological approach]

Related Experiment Video

Updated: Sep 30, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

R Bonato1, C Sorbara

  • 1Dipartimento di Farmacologia e Anestesiologia Egidio Meneghetti, Sezione di Anestesiologia e Rianimazione, Università degli Studi, Padova, Italy. rbonni@libero.it

Minerva Anestesiologica
|July 10, 2002
PubMed

Insights

Anesthesiologists can optimize care for patients with congenital heart disease (CHD) undergoing noncardiac surgery by understanding lesion pathophysiology. Individualized anesthetic plans focusing on hemodynamic management are crucial for maintaining pulmonary blood flow and cardiac output.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Pediatric Cardiology

Context:

  • Managing patients with congenital heart disease (CHD) presents unique challenges during noncardiac surgery.
  • Understanding the specific pathophysiology of congenital heart defects is essential for effective anesthetic planning.
  • Anesthetic management requires careful consideration of altered hemodynamics and potential complications.

Purpose:

  • To outline a systematic approach for anesthetic management of noncardiac surgery in patients with congenital heart disease.
  • To emphasize the importance of understanding the pathophysiology of various CHD lesions.
  • To guide anesthesiologists in developing individualized anesthetic strategies.

Summary:

  • Congenital heart disease (CHD) is categorized into obstructive, increased pulmonary blood flow, and decreased pulmonary blood flow lesions.
  • Anesthetic goals include preserving ventricular function and vascular resistances to maintain pulmonary blood flow, oxygenation, and forward cardiac output.
  • An individualized approach, considering patient-specific hemodynamic needs and controllable variables, is paramount.

Impact:

  • Facilitates rational and tailored anesthetic planning for a complex patient population.
  • Aims to improve perioperative outcomes for individuals with congenital heart disease undergoing noncardiac procedures.
  • Enhances the understanding of how anesthetic choices impact hemodynamics in CHD patients.

More Related Videos

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...